Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A

NCT04069533 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Fanconi Anemia Complementation Group A

Interventions

BIOLOGICAL: RP-L102

Sponsor

Rocket Pharmaceuticals Inc.